D. Medical Receives Registration Certificate From Israel's Ministry of Health For Its Spring Universal Infusion Sets
D. Medical Industries Ltd. (NASDAQ: DMED) announced today that it has received a registration certificate to market its Spring™ Universal Infusion Sets in Israel.
According to the International Diabetes Federation, approximately 320 thousand diabetes patients live in Israel. That number is expected to grow as the population ages.
Efri Argaman, D. Medical's Chief Executive Officer, commented, "We continue to pursue regulatory clearances for our Spring Universal Infusion Sets in various target markets in support of our goal of generating meaningful revenues and reaching positive margins as quickly as possible. Receiving this approval in our homeland, a recognized world center for Diabetes research, is particularly satisfying for us. We are now in the process of establishing a domestic distribution partnership and expect to be in a position to make this groundbreaking product commercially available here soon."
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.